ONTARIO, Calif., Nov. 3, 2023 /PRNewswire/ — In the past October, the Dollarfix brand, which focuses on car diagnostics and car owners’ various car lives, was officially launched on various online channels. A brand-new automotive lifestyle brand that aims to enhance your driving experience. Their mission is to simplify car repairs and maintenance for everyone, and… Continue reading Official Release, New Brand – Dollarfix Elevating Your Automotive Lifestyle with Innovative Tools and Products
Category: Newswire
Worksite Wellness Council of Massachusetts Announces its Eighth Annual Employer Award Winners
Awards recognize successful corporate health improvement and wellness programs BOSTON, Nov. 3, 2023 /PRNewswire/ — The Worksite Wellness Council of Massachusetts (WWCMA) is pleased to announce the winners of its eighth annual WorkWell Massachusetts Awards, powered by Healthiest Employers. This awards program recognizes achievements in developing, implementing, and participating in corporate health improvement and wellness programs. “It… Continue reading Worksite Wellness Council of Massachusetts Announces its Eighth Annual Employer Award Winners
Clean Beauty and Innovation: Key Trends Shaping the Global Organic Liquid Soap Market
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Global Organic Liquid Soap Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028” report has been added to ResearchAndMarkets.com’s offering. The global organic liquid soap market has witnessed significant growth in recent years, driven by consumers’ increasing preference for natural and environmentally friendly personal care products. This… Continue reading Clean Beauty and Innovation: Key Trends Shaping the Global Organic Liquid Soap Market
Official Release, New Brand – Dollarfix Elevating Your Automotive Lifestyle with Innovative Tools and Products
ONTARIO, Calif., Nov. 3, 2023 /PRNewswire/ — In the past October, the Dollarfix brand, which focuses on car diagnostics and car owners’ various car lives, was officially launched on various online channels. A brand-new automotive lifestyle brand that aims to enhance your driving experience. Their mission is to simplify car repairs and maintenance for everyone, and… Continue reading Official Release, New Brand – Dollarfix Elevating Your Automotive Lifestyle with Innovative Tools and Products
What’s Shaping the B2B Tech Demand Gen Market Over the Next 12 Months?
What’s Shaping the B2B Tech Demand Gen Market Over the Next 12 Months? “The findings of this year’s State of Demand Gen report tell a story that demand gen tactics are shifting to focus more on precision and quality,” said Chris Rooke, Chief Executive Officer at Activate. “For example: Two-thirds of teams now have BDRs… Continue reading What’s Shaping the B2B Tech Demand Gen Market Over the Next 12 Months?
Technological Advancements Drive Innovation in Global Passive Optical Network Equipment Market, Meeting the Demands of the Digital Age
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Passive Optical Network Equipment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028” report has been added to ResearchAndMarkets.com’s offering. The Passive Optical Network Equipment Market is set to soar, with projections indicating it will reach a staggering USD 14.63 billion by the end of 2028.… Continue reading Technological Advancements Drive Innovation in Global Passive Optical Network Equipment Market, Meeting the Demands of the Digital Age
La Agencia Europea del Medicamento valida la solicitud de autorización de comercialización presentada por los Laboratorios Pierre Fabre para la combinación de BRAFTOVI® (encorafenib) y MEKTOVI® (binimetinib) para pacientes con cáncer de pulmón no microcítico (CPNM) avanzado con mutación BRAFV600
BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) muestran un beneficio clínico significativo en pacientes adultos con CPNM avanzado con mutación BRAFV600. La solicitud se fundamenta en los resultados del estudio PHAROS,1 que demostró una tasa de respuesta objetiva del 75% en pacientes sin tratamiento previo y del 46% en pacientes con tratamiento previo. Si se aprueba, la nueva… Continue reading La Agencia Europea del Medicamento valida la solicitud de autorización de comercialización presentada por los Laboratorios Pierre Fabre para la combinación de BRAFTOVI® (encorafenib) y MEKTOVI® (binimetinib) para pacientes con cáncer de pulmón no microcítico (CPNM) avanzado con mutación BRAFV600
St. Joseph’s Hospital to Open First Proton Radiation Therapy Center in Tampa Bay Area
BayCare Invests $33M to Deliver Advanced Care to Cancer Patients TAMPA, Fla., Nov. 3, 2023 /PRNewswire/ — Construction of the first proton therapy center to open in the Tampa Bay area is set to begin at St. Joseph’s Hospital Cancer Institute, bringing technologically advanced treatment closer to home for local cancer patients. Proton therapy delivers… Continue reading St. Joseph’s Hospital to Open First Proton Radiation Therapy Center in Tampa Bay Area
Addressing the Global HIV Challenge: Market for Diagnostics and Therapeutics Plays a Crucial Role in Combating HIV/AIDS
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Diagnostics and Therapeutics for HIV: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The global diagnostics and therapeutics for HIV market is expected to reach $39.3 billion in 2028 from $30.4 billion in 2023 at a CAGR of 5.3%. The global diagnostics and therapeutics for HIV market is… Continue reading Addressing the Global HIV Challenge: Market for Diagnostics and Therapeutics Plays a Crucial Role in Combating HIV/AIDS
Pierre Fabre Laboratories acelera su desarrollo en oncohematología gracias a la adquisición de la licencia de una inmunoterapia de células T revolucionaria en Norteamérica
Pierre Fabre Laboratories adquiere de Atara Biotherapeutics los derechos de comercialización de EBVALLO® en Estados Unidos, Canadá y el resto de mercados Tras un período de transición, Pierre Fabre Laboratories se hará cargo de todas las actividades de fabricación, clínicas y reglamentarias de EBVALLO® Esta adquisición estratégica permite a los Laboratorios Pierre Fabre afianzarse en… Continue reading Pierre Fabre Laboratories acelera su desarrollo en oncohematología gracias a la adquisición de la licencia de una inmunoterapia de células T revolucionaria en Norteamérica